(Registration form at the end of this announcement)

****   11th International Scientific Conference on   ******
*******  Lyme Disease and other Spirochetal &    **********
********            Tick-borne disorders                    ************

                              APRIL 25 - 26, 1998

Equitable Conference Center
787 Seventh Avenue (51st & 52nd), New York City

INCREASED EVIDENCE OF MOSQUITO CAPACITY TO TRANSMIT Borrelia burgdorferi  

Willy Burgdorfer, PhD, MD (Hon)
Discoverer of the Lyme bacterium, National Institutes of Health

Program Committee

Sam T. Donta, MD - Program Coordinator
                                Boston University School of Medicine

Edward M. Bosler, PhD - Stonybrook School of Medicine

James N. Miller, PhD - UCLA School of Medicine

Charles S. Pavia, PhD - New York Medical College

Ron Schell, PhD - University of Wisconsin Medical School

                         TARGET AUDIENCE
? Primary Care Physicians     ? Nurse Practitioners
? Researchers                               ? Medical Specialists
? Public Health Officials           ? Veterinarians

                         SATURDAY APRIL 25, 1998

8:00am Welcome & Keynote    ( 7:30 am Registration, sign-in)    

INCREASED EVIDENCE OF MOSQUITO CAPACITY TO TRANSMIT Borrelia burgdorferi  

Willy Burgdorfer, PhD, MD (Hon)   Discoverer of the Lyme bacterium, National
Institutes of Health

BASIC SCIENCES
Chairman: Dave Dorward, PhD (8:30am - 11:00am)
Complete Genome Sequence of Borrelia burgdorferi
   Claire M. Fraser, PhD, The Institute For Genomic Research

Identification and Characterization of Virulent Strain Associated Outer
Membrane Proteins of Borrelia burgdorferi
   John T. Skare, PhD, Texas A & M University

Borrelia burgdorferi Isolates from the Midwest and south
   James H. Oliver, PhD, Georgia Southern University

Survey for Borrelia Species among Reservoir Animals Captured in Forested Areas
of Greater Metropolitan Chicago
   Maria M. Picken, MD, PhD, Loyola University Medical Center    

Toxins of Borrelia burgdorferi
   Mark Cartwright, Suzanne Martin, Sam T. Donta, MD, Boston University School
of Medicine

In Vitro Evidence for Lymphocytic Membrane Cloaking by Borrelia burgdorferi
   David W. Dorward, PhD, NIAID, National Institutes of Health

TICK VECTORS AND ANIMAL MODELS
Chairman: Edward Bosler, PhD (11:00am - 1:50pm)
Tick Vectors of Borrelia burgdorferi
   John  Anderson, PhD, Connecticut Agriculture Experiment Station

Coinfections in Ticks and Animals
    Edward Bosler, PhD, SUNY at Stony Brook School of Medicine

Laboratory and Clinical Characterization of the Canine Monocytic Ehrlichiosis
Syndrome
        Ibulaimu Kakoma, DVM, PhD, College of Veterinary Medicine,              
                                              University of Illinois

Lyme Disease in Dairy Cattle
        Sandra L. Bushmich, MS, DVM, University of Connecticut

{*filter*}Corticosteroid Treatment of Dogs Infected with Borrelia burgdorferi
   Reinhard K. Straubinger, Dr. med. vet., PhD, Cornell University

LABORATORY TESTING
Chairmen: Ron Schell, PhD (1:50pm - 4:00pm)

Overview of Testing in Lyme Disease
        Ron Schell, PhD, University of Wisconsin Medical School

In Vivo Expressed Antigens
        Steven Schutzer, MD, University of Medicine and Dentistry of New Jersey

Antigen Detection of Borrelia burgdorferi in Urine
        Nick Harris, PhD, IGeneX Reference Laboratory

New System for Borrelia In Vitro Cultivation
        Paul H. Duray, MD, National Institutes of Health
                                              National Cancer Institute

Improving Culturing and Sensitivity to Antibiotics of Borrelia burgdorferi
Isolated from Patients with Early Lyme Disease
        Charles S. Pavia, PhD, New York Medical College

Diagnosis and Treatment
Chairmen: Sam Donta, MD and Ron Schell, PhD (4:00pm - 5:00pm)

Non-Lyme Disease Tick-Borne Disorders
        Julie Rawlings, MPH, Texas Department of Health

Coinfections in Patients on Long Island
        Bill Golde, PhD, SUNY at Stony Brook School of Medicine

Confirmatory Testing for Non-Lyme Disease Tick-borne Diseases
        Richard Tilton, PhD, Boston Biomedica Laboratories

6 pm - 8 pm  Reception - included in registration.

SUNDAY APRIL 26, 1998

8:00 am  Conference Open  (7:30 am  Registration, sign-in)

Host and Mammalian Histopathology in Borreliosis
        Paul H. Duray, MD, National Institutes of Health
                                                National Cancer Institute

Early Disease
        Anthony Lionetti, MD, Lyme Disease Diagnostic Center

New Epidemiologic Findings of the EM Rash and Lyme Disease Serology
        Dennis Parenti, MD, SmithKline Beecham Biologicals

Overview of Disseminated Lyme Disease  
        Kenneth Liegner, MD, Internal Medicine, Private Practice

Eye Findings in Disseminated Lyme Disease
        Robert L. Lesser, MD, Yale University School of Medicine

Neuropsychiatric Manifestations of Lyme Disease in Children
        Brian Fallon, MD, Columbia School of Medicine,
                                     NYS Psychiatric Institute

Clinical Characterization and Serological Data on 200 Patients PCR Positive for
Lyme Disease
        Anthony Lionetti, MD, Lyme Disease Diagnostic Center

Clinical Borreliosis in Missouri
        Edwin J. Masters, MD, Regional Primary Care Physician

Chronic Lyme Disease
        Sam Donta, MD, Boston University School of Medicine

Update on the NIH Intramural Chronic Lyme Disease Study
        Adriana Marques, MD, National Institutes of Health

Clinical Use of Macrolide Antibiotics in Treatment of Lyme Disease
        Sam T. Donta, MD, Boston University School of Medicine      

Designing Better Therapies - Panel discussion by the presenters.

LYME DISEASE COST-TO-SOCIETY  (2:45pm - 3:05pm)        
Lyme Disease Cost-to-Society and Symptomatology Survey
        Irwin T. Vanderhoof, PhD, Stern School of Business
                                                        Society of Actuaries

VACCINES
Chairman: James N. Miller, PhD  (3:05pm - 5:00pm)

Successful Results of Phase III Efficacy Trial of a Lipoprotein OspA Vaccine
        Dennis L. Parenti, MD, SmithKline Beecham Biologicals

Strategies for a Vaccine against European Borrelia
        Robert C. Huebner, PhD, Pasteur Merieux Connaught

Second Generation Vaccine as Potential Therapy - Decorin Binding Protein
        David R. Cassatte, PhD, MedImmune

Potential Limitations of the OspA Vaccine for Humans Based Upon Experimental
Studies in Animals
        James N. Miller, PhD, UCLA School of Medicine  
        Denise M. Foley, PhD Chapman University

NEW AT THIS CONFERENCE !
? New - Discoveries about Lyme disease bacterium in area formerly considered
nonendemic - the Midwest and South.

? New - Toxins given off by the LD bacterium that may  account for chronic
signs and symptoms.

? New - Vaccine trial results. Note: Your patients may be asking about this in
a few months.

? New - EM rashes are proved to have a wide variety of new shapes and sizes ..
it's not just a "Bull's-eye".

? New - Complete Bb genome sequence and the implications.

? New - Diagnosis & treatment information.

? New - Coinfections in ticks, animals, and people.

? Come meet the man who discovered the Lyme bacterium.

CME DISCLOSURE
Only one product, cefuroxime, is approved for use in Lyme disease. And, the
product is FDA approved for use only in Early Lyme Disease.  Discussion about
any other product involves "off-label" use.

Reviews of  Prior Conferences

Excellent quality of presentations! I liked the research/objective data and the
new developments.                               Researcher

All speakers were very well organized, focused, obvious experts and very
dedicated to their work and also grateful to the LDF for the honor to
participate. I haven't seen that in other medical conferences!  Topics were
pertinent and helpful to my practice.                    

                                                                                                                Physicians

Great scientific program with a good mix of research & clinical.              
                                                                                                                                                    Veterinarian

CME CREDITS
This activity has been planned and implemented in accordance with the
Essentials and Standards of the Accreditation Council for Continuing Medical
Education through the joint sponsorship of Boston University School of Medicine
and the Lyme Disease Foundation. Boston University School of Medicine is
accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this educational activity for a
maximum of 15 hours in Category 1 credit towards the AMA Physician's
Recognition Award.  Each physician should claim only those hours of credit that
he/she actually spent in the educational activity.

LEARNING OBJECTIVES

The purpose of this conference is to present the current status of clinical and
basic sciences with regards to several aspects of Lyme disease (LD); the basic
science about the Lyme disease pathogen Borrelia burgdorferi; coinfection;
patient diagnosis (including differential diagnosis, coinfections), treatment,
and management; and prevention.  

Upon completion of this program, participants should be able to:
? Recognize the complex nature of Borrelia burgdorferi in relation to host
response to infection
? Determine criteria for diagnosis and treatment of the various presentations
of LD
? Identify various approaches to and role of the laboratory testing of LD and
coinfections
? Diagnose neurologic LD and its many complex manifestations
? Identify the spectrum of problems associated with the etiology of chronic LD,
e.g. animal models and clinical data
? Assess the implications of genetic diversity of the LD spirochete on the
development of new diagnostic tests and vaccines.

TO REGISTER
Complete and send this form to the
Lyme Disease Foundation, 1 Financial Plaza, Hartford, CT 06103

TRAVEL
Huntington Hay Travel (800-783-9783) is ready to assist you with ...

read more »

Karen

Are there proceedings published. Defeinetly want this one? or a video

TIA

)
)             (Registration form at the end of this announcement)
)
)
)****   11th International Scientific Conference on   ******
)*******  Lyme Disease and other Spirochetal &    **********
)********            Tick-borne disorders                    ************
)
)                              APRIL 25 - 26, 1998
)
)Equitable Conference Center
)787 Seventh Avenue (51st & 52nd), New York City
)
)
)INCREASED EVIDENCE OF MOSQUITO CAPACITY TO TRANSMIT Borrelia burgdorferi  
)
)Willy Burgdorfer, PhD, MD (Hon)
)Discoverer of the Lyme bacterium, National Institutes of Health
)
)
)Program Committee
)
)Sam T. Donta, MD - Program Coordinator
)                                Boston University School of Medicine
)
)Edward M. Bosler, PhD - Stonybrook School of Medicine
)
)James N. Miller, PhD - UCLA School of Medicine
)
)Charles S. Pavia, PhD - New York Medical College
)
)Ron Schell, PhD - University of Wisconsin Medical School
)
)
)                         TARGET AUDIENCE
)? Primary Care Physicians    ? Nurse Practitioners
)? Researchers                              ? Medical Specialists
)? Public Health Officials          ? Veterinarians
)
)
)                         SATURDAY APRIL 25, 1998
)
)8:00am Welcome & Keynote    ( 7:30 am Registration, sign-in)    
)
)
)INCREASED EVIDENCE OF MOSQUITO CAPACITY TO TRANSMIT Borrelia burgdorferi  
)
)Willy Burgdorfer, PhD, MD (Hon)   Discoverer of the Lyme bacterium, National
)Institutes of Health
)  
)BASIC SCIENCES
)Chairman: Dave Dorward, PhD (8:30am - 11:00am)
)Complete Genome Sequence of Borrelia burgdorferi
)   Claire M. Fraser, PhD, The Institute For Genomic Research
)
)Identification and Characterization of Virulent Strain Associated Outer
)Membrane Proteins of Borrelia burgdorferi
)   John T. Skare, PhD, Texas A & M University
)                
)Borrelia burgdorferi Isolates from the Midwest and south
)   James H. Oliver, PhD, Georgia Southern University
)
)Survey for Borrelia Species among Reservoir Animals Captured in Forested Areas
)of Greater Metropolitan Chicago
)   Maria M. Picken, MD, PhD, Loyola University Medical Center    
)        
)Toxins of Borrelia burgdorferi
)   Mark Cartwright, Suzanne Martin, Sam T. Donta, MD, Boston University School
)of Medicine
)        
)In Vitro Evidence for Lymphocytic Membrane Cloaking by Borrelia burgdorferi
)   David W. Dorward, PhD, NIAID, National Institutes of Health
)
)TICK VECTORS AND ANIMAL MODELS
)Chairman: Edward Bosler, PhD (11:00am - 1:50pm)
)Tick Vectors of Borrelia burgdorferi
)   John  Anderson, PhD, Connecticut Agriculture Experiment Station
)
)Coinfections in Ticks and Animals
)    Edward Bosler, PhD, SUNY at Stony Brook School of Medicine
)
)Laboratory and Clinical Characterization of the Canine Monocytic Ehrlichiosis
)Syndrome
)       Ibulaimu Kakoma, DVM, PhD, College of Veterinary Medicine,              
)                                             University of Illinois
)
)Lyme Disease in Dairy Cattle
)       Sandra L. Bushmich, MS, DVM, University of Connecticut
)        
){*filter*}Corticosteroid Treatment of Dogs Infected with Borrelia burgdorferi
)   Reinhard K. Straubinger, Dr. med. vet., PhD, Cornell University
)
)
)LABORATORY TESTING
)Chairmen: Ron Schell, PhD (1:50pm - 4:00pm)
)
)Overview of Testing in Lyme Disease
)       Ron Schell, PhD, University of Wisconsin Medical School
)        
)In Vivo Expressed Antigens
)       Steven Schutzer, MD, University of Medicine and Dentistry of New Jersey
)        
)Antigen Detection of Borrelia burgdorferi in Urine
)       Nick Harris, PhD, IGeneX Reference Laboratory
)        
)New System for Borrelia In Vitro Cultivation
)       Paul H. Duray, MD, National Institutes of Health
)                                             National Cancer Institute
)        
)Improving Culturing and Sensitivity to Antibiotics of Borrelia burgdorferi
)Isolated from Patients with Early Lyme Disease
)       Charles S. Pavia, PhD, New York Medical College
)  
)Diagnosis and Treatment
)Chairmen: Sam Donta, MD and Ron Schell, PhD (4:00pm - 5:00pm)
)
)Non-Lyme Disease Tick-Borne Disorders
)       Julie Rawlings, MPH, Texas Department of Health
)
)Coinfections in Patients on Long Island
)       Bill Golde, PhD, SUNY at Stony Brook School of Medicine
)
)Confirmatory Testing for Non-Lyme Disease Tick-borne Diseases
)       Richard Tilton, PhD, Boston Biomedica Laboratories
)
)6 pm - 8 pm  Reception - included in registration.
)
)
)SUNDAY APRIL 26, 1998
)
)8:00 am  Conference Open  (7:30 am  Registration, sign-in)
)
)Host and Mammalian Histopathology in Borreliosis
)       Paul H. Duray, MD, National Institutes of Health
)                                               National Cancer Institute
)    
)Early Disease
)       Anthony Lionetti, MD, Lyme Disease Diagnostic Center
)        
)New Epidemiologic Findings of the EM Rash and Lyme Disease Serology
)       Dennis Parenti, MD, SmithKline Beecham Biologicals
)        
)Overview of Disseminated Lyme Disease  
)       Kenneth Liegner, MD, Internal Medicine, Private Practice
)        
)Eye Findings in Disseminated Lyme Disease
)       Robert L. Lesser, MD, Yale University School of Medicine
)        
)Neuropsychiatric Manifestations of Lyme Disease in Children
)       Brian Fallon, MD, Columbia School of Medicine,
)                                    NYS Psychiatric Institute
)        
)Clinical Characterization and Serological Data on 200 Patients PCR Positive for
)Lyme Disease
)       Anthony Lionetti, MD, Lyme Disease Diagnostic Center
)        
)Clinical Borreliosis in Missouri
)       Edwin J. Masters, MD, Regional Primary Care Physician
)        
)Chronic Lyme Disease
)       Sam Donta, MD, Boston University School of Medicine
)        
)Update on the NIH Intramural Chronic Lyme Disease Study
)       Adriana Marques, MD, National Institutes of Health
)        
)Clinical Use of Macrolide Antibiotics in Treatment of Lyme Disease
)       Sam T. Donta, MD, Boston University School of Medicine      
)        
)Designing Better Therapies - Panel discussion by the presenters.
)        
)LYME DISEASE COST-TO-SOCIETY  (2:45pm - 3:05pm)        
)Lyme Disease Cost-to-Society and Symptomatology Survey
)       Irwin T. Vanderhoof, PhD, Stern School of Business
)                                                       Society of Actuaries
)        
)VACCINES
)Chairman: James N. Miller, PhD  (3:05pm - 5:00pm)
)
)Successful Results of Phase III Efficacy Trial of a Lipoprotein OspA Vaccine
)       Dennis L. Parenti, MD, SmithKline Beecham Biologicals
)        
)Strategies for a Vaccine against European Borrelia
)       Robert C. Huebner, PhD, Pasteur Merieux Connaught
)        
)Second Generation Vaccine as Potential Therapy - Decorin Binding Protein
)       David R. Cassatte, PhD, MedImmune
)        
)Potential Limitations of the OspA Vaccine for Humans Based Upon Experimental
)Studies in Animals
)       James N. Miller, PhD, UCLA School of Medicine  
)       Denise M. Foley, PhD Chapman University
)
)
)NEW AT THIS CONFERENCE !
)? New - Discoveries about Lyme disease bacterium in area formerly considered
)nonendemic - the Midwest and South.
)
)? New - Toxins given off by the LD bacterium that may  account for chronic
)signs and symptoms.
)
)? New - Vaccine trial results. Note: Your patients may be asking about this in
)a few months.
)
)? New - EM rashes are proved to have a wide variety of new shapes and sizes ..
)it's not just a "Bull's-eye".
)
)? New - Complete Bb genome sequence and the implications.
)
)? New - Diagnosis & treatment information.
)
)? New - Coinfections in ticks, animals, and people.
)
)? Come meet the man who discovered the Lyme bacterium.
)
)
)
)CME DISCLOSURE
)Only one product, cefuroxime, is approved for use in Lyme disease. And, the
)product is FDA approved for use only in Early Lyme Disease.  Discussion about
)any other product involves "off-label" use.
)
)
)Reviews of  Prior Conferences
)
)Excellent quality of presentations! I liked the research/objective data and the
)new developments.                               Researcher
)
)All speakers were very well organized, focused, obvious experts and very
)dedicated to their work and also grateful to the LDF for the honor to
)participate. I haven't seen that in other medical conferences!  Topics were
)pertinent and helpful to my practice.                    
)      
)                                                                                                               Physicians
)
)Great scientific program with a good mix of research & clinical.              
)                                                                                                                                                           Veterinarian
)
)CME CREDITS
)This activity has been planned and implemented in accordance with the
)Essentials and Standards of the Accreditation Council for Continuing Medical
)Education through the joint sponsorship of Boston University School of Medicine
)and the Lyme Disease Foundation. Boston University School of Medicine is
)accredited by the ACCME to provide continuing medical education for physicians.
)
)Boston University School of Medicine designates this educational activity for a
)maximum of 15 hours in Category 1 credit towards the AMA Physician's
)Recognition Award.  Each physician should claim only those hours of credit that
)he/she actually spent in the educational activity.
)
)
)LEARNING OBJECTIVES
)
)The purpose of this conference is to present the current status of clinical and
)basic sciences with regards to several aspects of Lyme disease (LD); the basic
)science about the Lyme disease pathogen Borrelia burgdorferi; coinfection;
)patient diagnosis (including differential diagnosis, coinfections), treatment,
)and management; and prevention.  
)
)Upon completion of this program, participants should be able to:
)? Recognize the complex nature of Borrelia burgdorferi in relation to host
)response to infection
)? Determine criteria for diagnosis and treatment of the various presentations
)of LD
)? Identify various approaches to and role of the laboratory testing of LD and
)coinfections
)? Diagnose neurologic LD and its many complex manifestations
)? Identify the spectrum of problems ...

read more »

Will there be a Public Forum this year?

Cindy